Low Level Laser Therapy for Hair Preservation With Chemotherapy for Breast Cancer
The purpose of this study is to see whether low level laser therapy can help maintain normal hair growth on the scalp in people receiving chemotherapy, which is generally associated with hair loss.
|Study Design:||Allocation: Non-Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Supportive Care
|Official Title:||Low Level Laser Therapy for Hair Preservation With Chemotherapy for Breast Cancer|
- 10 Point Scale to evaluate hair loss [ Time Frame: Photographs evaluated weekly during treatment, one month post chemotherapy ] [ Designated as safety issue: No ]The primary objective is to evaluate the ability of Low-Level Laser Therapy (LLLT) to prevent chemotherapy induced alopecia in women receiving adjuvant chemotherapy for breast cancer.
|Low-Level Laser Therapy||
Procedure: Low-Level Laser Therapy
A LLLT device at 670 nm will be used for light application using lasers affixed in a rotating helmet apparatus. Treatment will be given twice weekly prior to commencing chemotherapy and will be administered once a week until one week after the last chemotherapy.
Chemotherapy is a common treatment given to patients with breast cancer. Many chemotherapy drugs cause rapid hair loss. While hair loss is temporary, this side effect is a significant concern for patients. Low level laser therapy has been shown to help make hair grow. It is hoped that it may stop hair loss from occurring.
Participants will be receiving 20 to 30 minute laser sessions to their scalp twice a week beginning two weeks before treatment begins until one week past the last chemotherapy session. . Photographs will be taken during each study participant's initial visit, during treatment visits, and one month following the final chemotherapy treatment.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01081106
|Principal Investigator:||Jamie Van Roenn, MD||Northwestern University|